Scottish Enterprise supports 200+ early stage companies

Entrepreneurial training in high demand

Scottish Enterprise has provided targeted support to 231 entrepreneurs leading early stage companies to increase their ambition, competitiveness and capacity for internationalisation.

The figure exceeds its first year target (130-180) of a three-year plan designed to provide high growth early stage companies in Scotland* with targeted training and support to give them the best chance for creating internationally competitive ventures. Over three years, Scottish Enterprise aims to assist 550-700 entrepreneurs in total.

To deliver on its objective of helping more companies in Scotland scale up and positively impact the economy, Scottish Enterprise provides tailored support aimed at different aspects of early stage company growth, from advice on commercialising ideas to growth funding and business management.

Help from Scottish Enterprise includes its High Growth Spinout and Start-Up programmes, as well as partnerships with other organisations and Scottish universities on initiatives such as the Engage Invest Exploit investor showcase.

Scottish Enterprise’s High Growth Spinout Programme supports the transition of pre-commercial leading-edge technologies, emerging from Scotland's universities, research institutes and NHS Boards, into high growth companies with secured investment. Entry criteria include a demonstrable market opportunity for the new technology, a team with a clear plan for commercialisation, a path to ownership of intellectual property rights and realistic project costs. Successful applications receive bespoke business mentoring and advice, funding and ongoing entrepreneurship training.

Recent examples of companies created through this support include Mironid, which recently completed an initial £4.3m Series A investment, and SIRAKOSS Limited, which has secured a series of patents in key international markets after its own successful Series A funding round of £3.1m.

The High Growth Start-Up programme helps growth entrepreneurs to create and develop new businesses which have the potential to achieve significant revenues (£5m) or external investment (£10m) within 5 years. It only works with businesses which meet its eligibility criteria after a rigorous assessment and evaluation of the business opportunity. It primarily focuses on companies working in the Energy, Technology and Engineering, Life Sciences and Chemicals and Digital sectors, but which often play into other sectors.

David Hunter, inventor and Managing Director of Shot Scope, a wearable golf game analytics tool, said that Scottish Enterprise support has been fundamental to his company’s successful launch of a brand new product. He said: “Without Scottish Enterprise support we wouldn’t be in the position we are today, having designed, manufactured and now launched a brand new wearable technology which will help golfers the world over improve their games.

“The support we’ve received has ranged from an initial SMART SCOTLAND grant to assistance with setting up a manufacturing facility in Scotland, guidance on business management, and an invitation to last year’s PGA Merchandise Show where we were able to introduce Shot Scope to various international markets.

“For entrepreneurs with the drive to make their ideas a reality, Scottish Enterprise can provide the advice and support at an early stage. This makes all the difference to a small company with big ambitions.”

East Coast Oil & Gas (EC-OG) operates in the oil and gas sector, having built an excellent track record in subsea intervention engineering services since 2013. EC-OG has designed and patented the Subsea Power Hub (SPH), a world-first renewable energy source. Still in its pre-commercialisation stage, it has worked closely with Scottish Enterprise to develop its commercial strategy.

Managing Director of EC-OG Richard Knox said: “The support available for start-up businesses in Scotland is tremendous, from Business Gateway through to Scottish Enterprise and various other initiatives. I’m often told by company leaders from other countries that they wish they could enjoy the same infrastructure that we have here, and I can only agree with them.

EC-OG is currently manufacturing its first prototypes of the SPH, offering it to the market in the following year, if not before.

Richard Knox continued: “Scottish Enterprise ‘got’ our concept from the beginning and provided real assistance and expertise around both oil and gas sector considerations and business development. This helped us take a step back and re-assess our business plan to make it more resilient, sustainable and ultimately more commercial.

“Having Scottish Enterprise to guide and support us has helped us to accelerate our initial timetable and expand our ambition to the point where we’re now looking at ourselves as a global business. We’ve worked hard to make our vision a reality, and we are very excited to bring this new product to market.”

Angela Scott is Chief Operating Officer of TC Biopharm which has worked with Scottish Enterprise since its inception. She said: “We approached Scottish Enterprise once we had a solid business plan for some assistance and advice on where to get funding. It responded by connecting us with the right partners and resources to get funding and find a suitable location to set-up. It also supported us with in-depth discussion and tailored advice on the best way to harness our ideas and the opportunities they present.

“In a few short years we have gone from a small founding team to 35 staff, based in cutting-edge facilities at Eurocentral, and with a very healthy pipeline of new products and commercial partnership opportunities both here and internationally. We could not have done this as effectively, or as quickly, without Scottish Enterprise’s helpful and proactive support.”

Eleanor Mitchell, High Growth Ventures Director at Scottish Enterprise said: “Companies like Shot Scope, East Coast Oil and Gas, Mironid, SIRAKOSS and TC Biopharm are perfect examples of many commercially viable, innovative and passionate companies looking to do great things in and beyond Scotland.

“It is so important to equip our early stage entrepreneurs from the beginning to think big and approach their ideas strategically, so that they have the best chance of success. By focussing entrepreneurship support at the crucial earlier stages of growth, we will help more companies develop sustainably, yet at pace, which will have a positive impact on the economy.”

Companies and entrepreneurs in Scotland in their first five years of operation which wish to explore the options in terms of mentoring and support should contact Scottish Enterprise’s general enquiries line on 0300 013 3385 or enquiries@scotent.co.uk.

Notes to editors

*Please note that the 231 companies described here work directly with Scottish Enterprise, whether or not they have attended any joint-funded or partner workshops or courses.

Businesses across the Highlands and Islands of Scotland receive innovation and business growth support from HIE, which also partners with Scottish Enterprise on Scotland Can Do Scale and a number of other interventions.

About Series A funding rounds

A Series A funding round is the first round of financing undergone for a new business venture after seed capital. Generally, this is the first time that company ownership is offered to external investors.

About Shot Scope

Shot Scope Technologies was founded in 2014 and is headquartered in Edinburgh, Scotland. From its inception, the one simple aim of the company has been to improve the way in which both amateur and professional golfers collect and analyze statistics from their game. The Shot Scope team, which consists of technology experts and golfers, including a former Walker Cup player, set out to develop smart wearable technology that was more intuitive and comprehensive than any current market offering.

Following two years of development, Shot Scope is delighted to announce the pre-sale of the Shot Scope wristband from January 2016 which provides the golfing community with the chance to reserve their wristband ahead of launch. Learn more at www.shotscope.com

About East Coast Oil & Gas

EastCoast Oil and Gas (EC-OG) is a dynamic company providing expertise to the global oil and gas industry, giving its clients access to leading experts who specialise in the wide spectrum of subsea intervention and production equipment.

EC-OG was founded at the beginning of 2013. The team is built around a group of experienced Designers, Engineers and Technical Specialists. EC-OG is employee-owned and fully focussed on the company’s core value of providing an excellent service to its clients.

EC-OG is currently in development of a world-first renewable subsea power hub. For more information visit www.ec-og.com

About TC Biopharm

Incorporated in late 2013, TC Biopharm (TCB) was initially set up as an equally-owned joint venture partnering with Medinet (Japan), TCB receiving an exclusive licence to Medinet patents for manufacture of innovative T cell therapies. Headquartered at the Pentlands Science Park outside Edinburgh, TCB is registered in Scotland (SC 453579).

Becoming operational from February 2014, the Company is developing ImmuniCell® an autologous anti-cancer immunotherapy which involves expansion of γδ T cells over several weeks - formulating a treatment for a wide variety of different tumour types. The technology was initially developed and commercialised by Medinet, who have successfully treated numerous cancer patients in Japan. Publicly listed on the Tokyo Stock Exchange, Medinet was founded in 1995, and is a lead contract development manufacturing organisation offering a full range of cell and tissue products in Japan. Medinet has conducted collaborative worldwide research with universities, medical/academic institutions, and other companies in Japan, US and Europe.

In January 2015, TCB was awarded a Manufacturer's Authorisation for Investigational Medicinal Products MIA (IMP) which permits manufacture and release of Advanced Therapy Medicinal Products (ATMPs) for use in clinical trials. Further to obtaining an MHRA manufacturing license, TCB was granted a Clinical Trial Authorisation (CTA) by the MHRA in September 2015. Learn more at www.tcbiopharm.com.

About Mironid

Mironid exists to improve the health and quality of life of patients by creating high value therapeutics addressing global unmet medical needs. It is currently building and progressing a pipeline of early stage drug discovery programmes that are initially targeted at cAMP degrading phosphodiesterase enzymes. These will generate novel and differentiated therapies for a range of therapeutic indications in areas of high unmet medical need. Learn more at http://www.mironid.com

About SIRAKOSS Limited

SIRAKOSS was spun out from the University of Aberdeen in 2011. The company completed proof of concept in 2012, and has since raised over $5m. Its IP portfolio is strengthened by granted patents in the critical US and European markets. Learn more at http://sirakoss.com/about/

About Engage Invest Exploit

EIE is a technology investor showcase featuring highly promising Scottish technology companies from the ICT & Digital, Life Sciences, and Energy sectors seeking funding from seed to A round.

In Scotland it is delivered by Informatics Ventures in partnership with Scottish Investment Bank and Scottish Enterprise. For more information visit http://www.eie-invest.com/

Contact Information